Beryllium disease

American Journal of the Medical Sciences

Volumn 321, Issue 1, 2001, Pages 89-98

  Saltini, Cesare ^a   Amicosante, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Beryllium; Human leukocyte antigen (HLA); Immunogenetic; Lung disease

Indexed keywords

BERYLLIUM; CYTOKINE; GAMMA INTERFERON; GLUTAMIC ACID; HLA ANTIGEN CLASS 2; INTERLEUKIN 2;

BERYLLIOSIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GRANULOMATOSIS; HUMAN; IMMUNOGENETICS; IMMUNOPATHOLOGY; LUNG FIBROSIS; T LYMPHOCYTE; TH1 CELL;

EID: 0035171327     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200101000-00013     Document Type: Conference Paper

References (113)

1. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T-cells
2. Metal toxicity and the respiratory tract
3. Metal fume fever: Characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value
4. Cytokines in metal fume fever
5. Granulomatous processes
6. Chronic beryllium disease - From the work place to cellular immunology, molecular immunogenetics, and back
7. Zirconium compound-induced pulmonary fibrosis
8. Hypersensitivity pneumonitis and exposure to zirconium silicate in a young ceramic tile worker
9. Interstitial lung granulomas as a possible consequence of exposure to zirconium dust
10. Granulomatous disease associated with pulmonary deposition of titanium
11. Sarcoidlike lung granulomatosis induced by aluminum dusts
12. The alveolitis of hypersensitivity pneumonitis
13. Hypersensitivity pneumonitis induced by Trichosporon cutaneum
14. Hypersensitivity pneumonitis-like reaction among workers exposed to piphenylmethane diisocyanate (MDI)
15. Risks of beryllium disease related to work process at a metal alloy and oxide production plant
16. Chemical pneumonia in workers extracting beryllium oxide. Report of three cases
17. Acute dermatitis and pneumonitis in beryllium workers: Review of 406 cases in 8-year period with follow up on recoveries
18. Delayed chemical pneumonitis in beryllium workers
19. Epidemiology of beryllium intoxication
20. Commentary and update: Chemical pneumonia in workers extracting beryllium oxide
21. Berylliosis a case report
22. Chronic beryllium disease in a precious metal refinery
23. Chronic beryllium disease in a dental laboratory
24. Contact dermatitis from beryllium in dental alloys
25. The pulmonary toxicity of beryllium
26. Beryllium disease screening in the ceramics industry
27. Epidemiology of beryllium sensitization and disease in nuclear workers
28. 3
29. Metalworking fluid-associated hypersensitivity pneumonitis: A workshop summary
30. Current problem of differentiating between beryllium disease and sarcoidosis
31. Beryllium disease, pathology and diagnosis
32. Beryllium disease
33. The nature and origin of Schaumann bodies
34. Beryllium disease
35. Beryllium disease: A continuing medical problem
36. Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity
37. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease
38. Diagnostic criteria for chronic beryllium disease (CBD) based on the U.K. registry 1945-1991
39. Blood cell proliferation to beryllium: Analysis by receive-operating characteristics
40. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing
41. Proliferative response of bronchoalveolar lymphocytes to beryllium
42. In vitro studies on granulomatous hypersensitivity to beryllium
43. Lymphocyte transformation in chronic pulmonary berylliosis
44. A study of the immunological aspects of chronic berylliosis
45. Appearance of T-cell populations during the time course of beryllium-induced granulomas
46. Biased accumulation of T-lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human hung
47. Chronic beryllium disease: An immune response by restricted families of T-cells
48. Interleukin-2 in the alveolitis of beryllium induced lung disease
49. In vitro demonstration of delayed hypersensitivity in patients with berylliosis
50. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease
51. Beryllium induces IL-2 and IFN-γ in berylliosis
52. Experimental beryllium-induced lung disease. I Differences in immunologic responses to beryllium compounds in strain 2 and 13 guinea pigs
53. An immune model of beryllium-induced pulmonary granulomata in mice
54. HLA-DPB1 Glutamate 69: A genetic marker of beryllium disease
55. Genetic markers in beryllium hypersensitivity
56. Interaction of genetic and exposure factors in the prevalence of berylliosis
57. Chemistry of peptides associated with MHC class I and class II molecules
58. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
59. Motifs and supermotifs for MHC class II binding peptides
60. The molecular basis of metal recognition by T-cells
61. Molecular basis of HLA-DP associated susceptibility to beryllium disease
62. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis
63. Patients with rheumatoid arthritis and gold-induced pneumonitis express two high-risk major histocompatibility complex patterns
64. Gold-specific T-cells in rheumatoid arthritis patients treated with gold
65. Distribution of the HL-A antigens in patients with pigeon breeder's lung
66. HLA-A, B, C and HLA-DR antigens in extrinsic allergic alveolitis (budgerigar fancier's lung disease)
67. Pigeon breeder's lung: Association with HLA-DR 3
68. Increase of HLA-DR7 in pigeon breeder's lung in a Mexican population
69. HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy
70. Molecular genetics of human immune responsiveness to Lolium perenne (rye) allergen Lol pIII
71. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPb chain
72. Circulating immune complexes in asbestos workers
73. The HL-A system in asbestos workers
74. HLA antigens in asbestosis
75. HLA-A and B antigen frequencies in an asbestos exposed population with normal and abnormal chest radiographs
76. Frequency of HLA antigen in asbestos workers with and without pulmonary fibrosis
77. HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers
78. The histocompatibility antigen in asbestos related disease
79. HLA antigens of the A and B locus in relation to the development of silicosis
80. Immunogenetic studies on HLA-DR in German coal miners with and without coal worker's pneumoconiosis
81. HLA and silicosis in Japan
82. Immunogenetic analysis of silicosis in Japan
83. TNF-α polymorphisms in ex-coal workers with and without coal worker's pneumoconiosis
84. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization
85. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study
86. Sarcoidosis mortality in the United States 1979-1991: An analysis of multiple-cause mortality data
87. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction
88. DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction
89. Identification of Mycobacterium avium complex in sarcoidosis
90. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction
91. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis
92. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction
93. Human herpesvirus 8 variants in sarcoid tissues
94. Alveolar maerophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interleukin-6 but not interleukin-1b
95. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset
96. Orosomucoid and haptogiobin types in patients with sarcoidosis
97. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis
98. HLA-B8/DR3 in sarcoidosis
99. HLA association in sarcoidosis: A study of two ethnic groups
100. Association of HLA B8 with spontaneous resolution in sarcoidosis
101. "The sarcoidosis map": A joint survey of clinical and immunogenetic findings in two European countries
102. Association of HLA-DR with sarcoidosis. Correlation with clinical course
103. Adverse effect of chronic tonsillitis on clinical course of sarcoidosis in relation to HLA distribution
104. Molecular genetic analysis of HLA class II genes in sarcoidosis
105. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis
106. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3
107. T-cell receptor variable region gene usage by CD4+ and CDS+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
108. Shared amino acid motifs in T-cell receptor beta junctional regions of bronchoalveolar T cells in patients with pulmonary sarcoidosis
109. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis
110. Genetic polymerphism of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis
111. No primary association between the 308 polymorphism in the tumor necrosis factor a promoter region and insulin dependent diabetes mellitus